Search Within

Wassim Abida

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (40)
  2. Meeting Abstract (24)
  3. Research Letter (2)
  4. Editorial (1)
Groups
  1. Department of Medicine (67)
  2. GSK Faculty (67)
  3. Genitourinary Oncology Service (67)
  4. Human Oncology and Pathogenesis Program (67)
  5. Solid Tumor Oncology Division (67)
  6. Sloan Kettering Institute Postdocs (49)

More Groups

People
  1. Howard Scher (43)
  2. David Solit (36)
  3. Nikolaus Schultz (32)
  4. Anuradha Gopalan (26)
  5. Charles Sawyers (24)
  6. Michael Berger (24)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (7)
  5. 2021 (3)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (8)
  3. Clinical Cancer Research (6)
  4. European Urology (3)
  5. JCO Precision Oncology (3)
  6. Nature (3)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (15)
  3. Nature Publishing Group (12)
  4. Cell Press (4)
  5. American Association for the Advancement of Science (3)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (67)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
    Journal Article

    Mu, P.; Zhang, Z.; Benelli, M.; Karthaus, W. R.; Hoover, E.; Chen, C. C.; Wongvipat, J.; Ku, S. Y.; Gao, D.; Cao, Z.; more...
    Science (2017)

    Fulltext@MSK | Save
  • Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Journal Article

    Pritchard, C. C.; Mateo, J.; Walsh, M. F.; De Sarkar, N.; Abida, W.; Beltran, H.; Garofalo, A.; Gulati, R.; Carreira, S.; Eeles, R.; more...
    New England Journal of Medicine (2016)

    Fulltext@MSK | Save
  • Investigation of a frequently mutated transcriptional repressor in prostate cancer, in particular its role in modulating androgen signaling and its effects on TMPRSS2-ERG dependent tumor maintenance
    Meeting Abstract

    Bose, R.; Abida, W.; Iaquinta, P.; Karthaus, W.; Armenia, J.; Wongvipat, J.; Doran, M.; Hieronymus, H.; Philip, W.; Liang, Y. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Brennan, R.; Armenia, J.; Curtis, K. R.; Gopalan, A.; Arcila, M. E.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer
    Meeting Abstract

    Mu, P.; Cao, Z.; Hoover, E.; Wongvipat, J.; Huang, C. H.; Karthaus, W.; Abida, W.; De Stanchina, E.; Sawyers, C.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Curtis, K. R.; Taylor, B. S.; Arcila, M. E.; Brennan, R.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Integrative clinical genomics of advanced prostate cancer
    Journal Article

    Robinson, D.; Van Allen, E. M.; Wu, Y. M.; Schultz, N.; Lonigro, R. J.; Mosquera, J. M.; Montgomery, B.; Taplin, M. E.; Pritchard, C. C.; Attard, G.; more...
    Cell (2015)

    Fulltext@MSK | Save